CorMedix Inc. Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from Q2 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
CorMedix Inc. quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from Q2 2018 to Q2 2024.
  • CorMedix Inc. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending June 30, 2024 was -$14.2M, a 25.5% decline year-over-year.
  • CorMedix Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was -$30.3M, a 2.81% decline from 2021.
  • CorMedix Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was -$29.5M, a 8.32% decline from 2020.
  • CorMedix Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2020 was -$27.2M, a 26.5% decline from 2019.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$14.2M -$2.88M -25.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$15.9M -$5.29M -50.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q2 2023 -$11.3M -$3.08M -37.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$10.6M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 -$6.85M +$1.72M +20% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$8.19M -$2.31M -39.2% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q3 2021 -$8.57M -$1.97M -29.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$5.88M +$3.07M +34.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q3 2020 -$6.6M -$1.34M -25.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$8.95M -$3.19M -55.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q3 2019 -$5.26M +$4.97M +48.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$5.76M +$2.8M +32.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q3 2018 -$10.2M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$8.56M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.